is expected to be commissioned in Q3FY22. With the new expanded capacity in the sugar biz, the management is aiming at overall sugar revenues to cross 1000Cr in next 2 to 3 years.
Current Sugar revenues are 496Cr.
JBCHEPHARM
— Saket Reddy (@saketreddy) July 16, 2021
Double Top Buy, Super Pattern - Bullish and T20 Pattern - Bullish triggered above 1886.26 daily close on 1% Box Size chart. https://t.co/bzIsbWjbEP pic.twitter.com/JQVkao635V
ALKEM
— Saket Reddy (@saketreddy) January 8, 2021
The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Double Top Buy above 3013 daily close on 3% box size chart, DTB active on 1% chart. pic.twitter.com/ToYx5T3Reb
The story doesn\u2019t say you were told not to... it says you did so without approval and they tried to obfuscate what you found. Is that true?
— Sarah Frier (@sarahfrier) November 15, 2018